R.F. Medical is a global Small but Powerful Giant that researches high frequency medical equipment. After its establishment in 2003, the corporation has continuously invested in R&D, expanding treatment to liver cancer, fibroids, lung cancer, kidney cancer, thyroid tumor, metastasis cancer, and Varicose veins.
CEO Jeon Myung-gi stated that “the medical equipment world market has been rapidly evolving, with safe and less invasive medical technology as its foundation. Of those technologies, high frequency treatment is in the center, and is applicable in various medical fields. Since its establishment, R.F. Medical has led the new market through R&D centered high frequency technology.” Minimally invasive medical technology is a surgical method that minimizes incision and resection.
R.F. Medical launched ‘Mygen’, a high frequency medical equipment. Due to the difficult technology, only 6 corporations world wide (including R.F. Medical) manufactures high frequency equipment. By assigning 20% of its workers to R&D, R.F. Medical was able to receive 11 domestic high frequency surgical equipment patents as well as 5 overseas patents in the United States, China, Europe, Japan, et cetera. R.F. Medical also holds international authentication such as ISO9001, ISO13485, Europe CE, as well as national authentication in the United States, China, Taiwan, Russia, Saudi Arabia, and Egypt. Their products are recognized for its quality and safety, and the corporation is currently exporting to over 50 nations. R.F. Medical also distributes its products to world class hospitals including Johns Hopkins University hospital and Stanford University hospital. This is why 80% of their overall profits comes from overseas exports.
R.F. Medical’s successes were recognized by the Ministry of SMEs and Startups, and was titled the global Small but Powerful Giant in 2020. CEO Jeon expressed his joy by stating “after being selected as a Small but Powerful Giant our corporation’s popularity increased, resulting in a more positive customer reception as well as better manpower for recruiting new employees." The corporation was also selected as “World Class Product of Korea fostering enterprise," hosted by South Korea's Ministry of Trade, Industry and Energy and KOTRA. R.F. Medical was also titled "well-spent enterprise" through their continuous donations to the Korean Red Cross and Doctors Without Borders.
Other than high frequency medical equipment, R.F. Medical recently expanded into different fields such as the anesthetic catheter, disposable biopsy needle, disposable puncture needle, and other medical accessories. By cooperating with heart disease medical technology corporation Tau-Pnu, they plan on co-developing a ‘Hypertrophic cardiomyopathy high frequency system.'
CEO Jeon states that “the medical equipment industry, alongside the IT industry, is the most important industry for the future. R.F. Medical and our workers have tried our best to secure research manpower and invest in research development, in order to stabilize the foundation of domestic medical technology as well as follow the speed of the medical technological advancement. We plan on creating even more minimally invasive and medically effective equipment through endless pioneering spirit and craftsmanship. RF Medical will take part in creating a healthy humanity as the leader of the latest medical equipment makers. Our plan is to become one of the Big Three in the high frequency medical equipment industry."
[Editor's Note: Money Today collaborates with the Seoul Business Agency to provide media usage, marketing and consulting to companies in Seoul that show innovative growth and global growth competitiveness.]